Home » Newsletters » BioWorld

BioWorld

June 5, 1992

View Archived Issues

THURSDAY'S STOCKS

CORTEX PATENT FOR PROTEIN MARKER

RIBI'S IMMUNOSTIMULANT ENTERS PHASE I

XOMA'S E5 SUFFERS ANOTHER BLOW FROM FDA

PHARMOS COMPLETES PHASE I TRIAL

BIOMATRIX GETS $250,000 SBIR

WARRANT EXPIRATION DATE NOT EXTENDED

ISRAEL APPROVES BTGC'S OPHTHALMIC DRUG

BRITISH BIO CROSSES THE POND FOR IPO

GREENWICH SUED BY SHAREHOLDER

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026